J Korean Ophthalmol Soc.  2014 Apr;55(4):541-547.

The Intima Media Thickness (IMT) as Measured by Carotid Ultrasonography in Patients with Retinal Vascular Diseases

Affiliations
  • 1Department of Ophthalmology, Maryknoll Hospital, Busan, Korea. pjm1438@hanmail.net
  • 2Kim's Eye Clinic, Cheongju, Korea.
  • 3Department of Ophthalmology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.

Abstract

PURPOSE
To evaluate the findings of carotid ultrasonography performed on patients with retinal vascular disease and to determine the risk of cardiovascular disease and association of retinal vascular disease and cardiovascular disease.
METHODS
From December 2009 to May 2012, patients diagnosed with central retinal artery occlusion (CRAO, n = 18), central retinal vein occlusion (CRVO, n = 23), and branch retinal vein occlusion (BRVO, n = 68) underwent carotid ultrasonography. We evaluated the intima-media thickness (IMT) of the common carotid artery (CCA) and the internal carotid artery (ICA), stenosis and the number of plaques, and then compared these results with those of a healthy control group (n = 221).
RESULTS
The mean CCA-IMT and ICA-IMT were significantly higher in the CRAO and BRVO groups compared with the control group. On the contralateral side, CCA-IMT was increased in the CRAO, BRVO, and CRVO groups and ICA-IMT was increased in the CRAO and BRVO groups compared with the control group. Contralateral CCA stenosis was higher in the CRVO group (9.1%) and ipsilateral ICA stenosis in CRAO group (21.7%) was significantly higher than that of the control group. Plaque was observed better in all groups compared with the control group. The proportion of patients risk for cardiovascular disease, i.e. those who had IMT thickenesses more than 1.0 mm, was higher in the CRAO and BRVO groups compared with the control group.
CONCLUSIONS
The carotid ultrasound findings of patients with retinal vascular diseases showed increased IMT and plaque. The group of patient at risk for cardiovascular disease, which was defined with carotid artery IMT, was higher in patients with retinal vascular disease. Therefore, in patients with retinal vascular disease, carotid artery ultrasonography and the overall management and treatment of cardiovascular disease are necessary.

Keyword

Branch retinal artery occlusion; Carotid ultrasonography; Central retinal artery occlusion; Central retinal vein occlusion; Intima-media thickness

MeSH Terms

Cardiovascular Diseases
Carotid Arteries
Carotid Artery, Common
Carotid Artery, Internal
Constriction, Pathologic
Ultrasonography
Humans
Retinal Artery Occlusion
Retinal Vein
Retinal Vein Occlusion
Retinaldehyde*
Ultrasonography*
Vascular Diseases*
Retinaldehyde

Figure

  • Figure 1. The measurement diagram of carotid artery in-tima-media thickness. The IMT is define as a distance between lumen intima interface and media adventitia interface at the far wall of carotid artery. In the B-mode ultrasonography of carotid artery, the intima show hyperechoic, the media show hy-poechoic and the adventitia show hyperechoic.

  • Figure 2. Comparisons of the ipsilateral carotid intima-media thickness among the patients with retinal vascular disease and the control group. CRAO = central retinal artery occlusion; CRVO = central retinal vein occlusion; BRVO = branch retinal vein occlusion; CCA = common carotid artery; ICA = internal carotid artery; IMT = intima-media thickness.

  • Figure 3. Proportion of Carotid artery stenosis in the patients with retinal vascular disease and the control group. CRAO = central retinal artery occlusion; CRVO = central retinal vein occlusion; BRVO = branch retinal vein occlusion; CCA = common carotid artery; ICA = internal carotid artery.

  • Figure 4. Proportion of high risk groups according the ipsilateral carotid artery IMT in the patients with retinal vascular disease and the control group. CRAO = central retinal artery occlusion; CRVO = central retinal vein occlusion; BRVO = branch retinal vein occlusion; CCA = common carotid artery; ICA = internal carotid artery; IMT = intima-media thickness.


Reference

References

1. Bullock JD, Falter RT, Downing JE, Snyder HE. Ischemic oph-thalmia secondary to an ophthalmic artery occlusion. Am J Ophthalmol. 1972; 74:486–93.
2. Breslin DJ, Gifford RW Jr, Fairbairn JF 2nd, Kearns TP. Prognostic importance of ophthalmoscopic finding in essential hypertension. JAMA. 1966; 195:335–8.
3. Feussner JR, Matchar DB. When and how to study the carotid arteries. Ann Intern Med. 1988; 109:805–18.
Article
4. Smith SC Jr, Amsterdam E, Balady GJ, et al. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II. Circulation. 2000; 101:E12–6.
5. Pearsn TA. New tools for coronary risk assessment: what are their advantages and limitations? Circulation. 2002; 105:886–92.
6. Chambless LE, Folsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 2000; 151:478–87.
Article
7. O’Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999; 340:14–22.
Article
8. Nowak J, Nilsson T, Sylvén C. Potential of carotid ultrasonography in the diagnosis of coronary artery disease: a comparison with ex-ercise test and variance ECG. Stroke. 1998; 29:439–46.
9. Suh DC, Lee SH, Kim KR, et al. Pattern of atherosclerotic carotid stenosis in Korean patients with stroke: different involvement of intracranial versus extracranial vessels. AJNR Am J Neuroradiol. 2003; 24:239–44.
10. Cote R, Barnett HJ, Taylor DW. Internal carotid occlusion: a prospective study. Stroke. 1983; 14:898–902.
Article
11. Peternel P, Keber D, Videcnik V. Carotid arteries in central retinal vessel occlusion as assessed by Doppler ultrasound. Br J Ophthal. 1989; 73:880–3.
Article
12. Klien BA, Olwin JH. A survey of the pathogenesis of retinal venous occlusion, emphasis upon choice of therapy and an analysis of the therapeutic results in fifty-three patients. AMA Arch Ophthalmol. 1956; 56:207–47.
13. Klien BA. Sidelights on retinal venous occlusion. Am J Ophthalmol. 1966; 61:25–36.
Article
14. CASSADY JV. Central retinal vein thrombosis. Am J Ophthalmol. 1953; 36:331–5.
Article
15. Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology. 1983; 90:458–74.
Article
16. Hayreh SS. Pathogenesis of occlusion of the central retinal vessels. Am J Ophthalmol. 1971; 72:998–1011.
Article
17. Marin-Sanabria EA, Kondoh T, Yamanaka A, Kohmura E. Ultrasonographic screening of carotid artery in patients with vascular retinopathies. Kobe J Med Sci. 2005; 51:7–16.
18. Matsushima C, Wakabayashi Y, Iwamoto T, et al. Relationship between retinal vein occlusion and carotid artery lesions. Retina. 2007; 27:1038–43.
Article
19. Sayag D, Gotzamanis A, Brugniart C, et al. Retinal vein occlusion and carotid Doppler imaging. J Fr Ophthalmol. 2002; 25:826–30.
20. Cheung N, Klein R, Wang JJ, et al. Traditional and novel cardiovascular risk factor for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci. 2008; 49:4297–302.
21. Choi SY, Kim D, Kang JH, et al. Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis. Korean J Hepatol. 2008; 14:77–88.
Article
22. Stojakovic T, Scharnagl H, März W, et al. Low density lipoprotein triglycerides and lipoprotein are risk factors for retninal vascular occlusion. Clin Chim Acta. 2007; 382:77–81.
23. Su TC, Chien KL, Jeng JS, et al. Age-and gender-associated determinants of carotid intima-media thickness: a community-based study. J Atheroscler Thromb. 2012; 19:872–80.
Article
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr